Amyotrophic lateral sclerosis proteomic signature and treatment with mesenchymal stem cell-derived extracellular vesicles

ABSTRACT: identifying the proteomic signature of ALS and how this is changed after treatment with MSC-EVs

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Stem Cell, Cell Culture, Bone Marrow

DISEASE(S): Amyotrophic Lateral Sclerosis

SUBMITTER: Suzy Varderidou  

LAB HEAD: Suzy Varderidou-Minasian, Maarten Altelaar, Jeroen Pasterkamp, Magdalena Lorenowicz

PROVIDER: PXD034824 | Pride | 2026-09-14

REPOSITORIES: Pride